ACE2 and COVID-19: The team with De Buyzere14 recently demonstrated that polymorphisms of the host's angiotensin-converting enzyme 2 (ACE2), which is involved in SARS-CoV-2 cell entry and infection, may explain the epidemiology of the disease worldwide, with a possible correlation between the geographic distribution of variants and the prevalence of COVID-19.